Shares of Seattle Genetics dropped 2.77% to $175.13 at 11:42 EST on Tuesday, after three sequential sessions in a row of losses. NASDAQ Composite is jumping 0.08% to $13,647.29, after five consecutive sessions in a row of gains. This seems, as yet, a somewhat positive trend trading session today.

Seattle Genetics’s last close was $180.12, 22.16% below its 52-week high of $213.94.

Seattle Genetics’s Sales

Seattle Genetics’s sales growth is 102.6% for the current quarter and 60.8% for the next. The company’s growth estimates for the current quarter and the next is 514.3% and 72.4%, respectively.

Seattle Genetics’s Revenue

Year-on-year quarterly revenue growth grew by 397.9%, now sitting on 1.86B for the twelve trailing months.


Seattle Genetics’s last day, last week, and last month’s average volatility was a negative 1.46%, a negative 0.62%, and a negative 0.43%, respectively.

Seattle Genetics’s last day, last week, and last month’s high and low average amplitude percentage was 5.50%, 3.51%, and 3.45%, respectively.

Seattle Genetics’s Stock Yearly Top and Bottom Value

Seattle Genetics’s stock is valued at $175.13 at 11:42 EST, way under its 52-week high of $213.94 and way higher than its 52-week low of $90.57.

Seattle Genetics’s Moving Average

Seattle Genetics’s worth is below its 50-day moving average of $184.87 and under its 200-day moving average of $177.31.


Please enter your comment!
Please enter your name here